Related Experiment Videos
Clinical trials of antitumor agents: experimental design and timeline considerations
1Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
The Cancer Journal From Scientific American
|May 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.
General physiology and biophysics·2007
The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2002
The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts.
Biochemical pharmacology·2002
Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
The cancer journal from Scientific American·2000
Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
The cancer journal from Scientific American·2000
Negative margin status improves local control in conservatively managed breast cancer patients.
The cancer journal from Scientific American·2000
The value of postlumpectomy mammogram in the management of breast cancer patients presenting with suspiciouis microcalcifications.
The cancer journal from Scientific American·2000
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia.
The cancer journal from Scientific American·2000
Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
The cancer journal from Scientific American·2000
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.
The Journal of experimental medicine·2026
Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.
Molecular cancer therapeutics·2026
Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.
Clinical pharmacology and therapeutics·2026
Payload-Free [89Zr]Zr-DFO*-sq-Enfortumab ImmunoPET for Imaging Nectin-4 Expression in Bladder Cancer.
Molecular pharmaceutics·2026